LORIE FREITAS: Open Payments
NPI 1154385722 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 52 payments from 17 companies in 2025. Trend: 2023 $1,096 · 2024 $1,288 · 2025 $1,198
Food & beverage: $1,198
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $202 |
| ABBVIE INC. | 12 | $179 |
| Novo Nordisk Inc | 7 | $122 |
| PFIZER INC. | 1 | $98 |
| Abbott Laboratories | 1 | $84 |
| Astellas Pharma US Inc | 3 | $79 |
| Phathom Pharmaceuticals, Inc. | 6 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Antares Pharma, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $44 |
Products named: QULIPTA, BREZTRI, ZAVZPRET, Ozempic, FREESTYLE LIBRE 3, Veozah, VOQUEZNA, XIFAXAN.
Industry payments across FL — which companies pay providers there.
